Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > A revolution for the science of diagnosis

The device uses nanotechnology to detect biomarkers, which can reveal the presence of different diseases in the body
© Shutterstock
The device uses nanotechnology to detect biomarkers, which can reveal the presence of different diseases in the body © Shutterstock

Abstract:
A team of scientists at the University of Leeds in the UK has invented a biosensor device that can identify disease using nanotechnology. The device, which may revolutionise the science of diagnosis, uses antibodies to detect biomarkers, molecules in the body used to identify disease. The aim of the ambitious ELISHA project, backed by the EU with EUR 2.7 million in funding, is to reduce diagnosis time to 15 minutes. The new invention may be on sale in just three years.

A revolution for the science of diagnosis

Europe | Posted on November 12th, 2008

There are many shortcomings to the current method of disease diagnosis, which was developed in the 1970s and is based on analysis of blood and urine samples. The tests have to be carried out in a pathology lab by highly trained staff, they take about two hours and are expensive. A simpler technique which would allow swifter diagnosis at less expense and in more a more convenient location, such a doctor's surgery, would be less intimidating for patients and more cost-effective for hospitals and health services.

Enter ELISHA (Electronic Immuno-Interfaces and Surface Nanobiotechnology: A Heteroxical Approach) and its brand new biosensor diagnosis device. A team of nine partners from five EU countries including universities, research institutes and SMEs developed the device which will make diagnosis both less expensive and more flexible to apply.

Dr Paul Millner from the faculty of biological sciences at the University of Leeds says, ‘We believe this to be the next generation diagnostic testing. We can now detect almost any analyte - a substance associated with disease - faster, cheaper and more easily than the current accepted testing methodology. We think this could revolutionise detection.'

The ELISHA device, which could be on sale in three years, is currently the size of a credit card payment machine, but the consortium plans to slim it down to the size of a mobile phone. It uses nanotechnology - manipulation of matter at microscopic scales - to detect biomarkers in blood or urine. It then gives a yes or no answer to the presence of a particular disease. Different microchips are inserted in the device to test for different diseases.

Dr Millner says, ‘We've designed simple instrumentation to make the biosensors easy to use and understand. They will work in a format similar to the glucose biosensor testing kits that diabetics currently use.'

The device could be used to identify a wide variety of diseases including prostate and ovarian cancer, strokes, heart disease, multiple sclerosis and fungal infections. The ELISHA consortium believes that it could also be versatile enough to detect tuberculosis and HIV. Its swiftness of response will mean both faster diagnosis of disease and referral to consultants.

The ELISHA technology has great potential for the future. ELISHA project manager Dr Tim Gibson says, ‘The analytes used in our research only scratch the surface of the potential applications. We've also shown that it can be used in environmental applications, for example to test for herbicides or pesticides in water and antibiotics in milk.'

####

For more information, please click here

Copyright © European Commission

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

Energy Research Facility Construction Project at Brookhaven Lab Wins U.S. Energy Secretary's Achievement Award April 16th, 2014

Nanomedicine

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014

PAM-XIAMEN Offers UV LED wafer April 15th, 2014

Nanocrystalline cellulose modified into an efficient viral inhibitor April 15th, 2014

Sensors

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014

LetiDays Grenoble to Present Multiple Perspectives on Development, Challenges and Markets for the IoT April 14th, 2014

In latest generation of tiny biosensors, size isn't everything: UCLA researchers overturn conventional wisdom on nanowire-based diagnostic devices April 11th, 2014

Discoveries

Scientists Capture Ultrafast Snapshots of Light-Driven Superconductivity: X-rays reveal how rapidly vanishing 'charge stripes' may be behind laser-induced high-temperature superconductivity April 16th, 2014

Scientists observe quantum superconductor-metal transition and superconducting glass: A team including MIPT physicist observed quantum superconductor-metal transition and superconducting glass April 16th, 2014

UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014

Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014

Announcements

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

Energy Research Facility Construction Project at Brookhaven Lab Wins U.S. Energy Secretary's Achievement Award April 16th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE